Adventrx CFO resigns; new president takes the helm

By Elaine Rigoli

Tampa, Fla., Sept. 8 - Adventrx Pharmaceuticals, Inc. announced Friday that Carrie Carlander has resigned from her positions as the company's chief financial officer, vice president of finance, treasurer and secretary.

Robert Daniel, currently the company's controller, has been appointed acting chief financial officer and treasurer. Patrick Keran, the company's general counsel, has been appointed secretary.

Further, James A. Merritt, a board-certified oncologist, has been appointed president, a position previously held by Evan M. Levine, who will continue to serve as chief executive officer and a member of the company's board of directors.

Merritt will also serve as chief medical officer, a newly created position.

Adventrx is a biopharmaceutical research and development company based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.